QNT

27.7400.79%
JJ

Joseph Jimenez

Lead Independent Director

Mr. Joseph Jimenez, Jr., also known as Joe, MBA, is an Independent Director of Quantinuum Inc. since May 2026. Mr. Jimenez is Scientific advisor & director of Orca Biosystems Inc. He is Director of Oblenio Bio, Inc. He serves as Director of Tempero Bio. He serves as Special Advisor to the Board at Century Therapeutics, Inc. He serves as Director at Via Nova Therapeutics Inc. He serves as Director at Ancora Bio Inc. He serves as the Co-Founder & MD at Aditum Bio Management Company, LLC. He serves as Non-Executive Director at Versanis Bio, Inc. He served as an Independent Chairman of the Board at Century Therapeutics, Inc. since February 2021 until August 14, 2025 and Director since August 2019 until August 14, 2025. He served as an Independent Director at Graphite Bio, Inc. since June 2020 until March 21, 2024. He has served as Director of The Procter & Gamble Co. since March 1, 2018 and has been its Lead Independent Director since 2021. He joined Century's Board of Directors in 2020. He serves as a Director at uBiome, Inc., since September 2018. He also serves as Independent Director of General Motors Company and The Proctor & Gamble Company. He served as Chief Executive Officer at Novartis (Hellas) S.A.C.I. He serves as Director at General Motors Co since 2015. He served as the Chief Executive Officer at Novartis International AG and Novartis Vaccines and Diagnostics, Inc. from 2010 until his retirement on January 31, 2018. Prior to this role, he held several senior positions at Novartis from 2007 to 2010, including Division Head, Novartis Pharmaceuticals and leadership of the company’s Consumer Health Division. He served as Director at Blue Nile, Inc. from March 2000 to August 2008. He served as Chief Executive Officer at Novartis Consumer Health Division from April 2007 until October 2007. He was Head of Novartis’ Pharmaceuticals Division from October 2007 to 2010. He served at Blackstone Group L.P. Mr. Jimenez was an Advisor to the Blackstone Group L.P. from 2006 to 2007. From September 2001 to April 2006, he served as an Executive Vice President at H.J. Heinz Company. He also served as President and Chief Executive Officer of Heinz Europe from July 2002 to April 2006. From November 1998 to July 2002, he served as President and Chief Executive Officer at Heinz North America. Prior to joining Heinz, he held various leadership positions at ConAgra Foods Inc. (“ConAgra”), including President and Senior Vice President of two operating divisions from 1993 to 1998. Prior to this role, he held several other senior positions at Novartis from April 2007 to 2010, as well as various leadership roles at H. J. Heinz Company from 1999 to 2006, including Executive Vice President, President and Chief Executive Officer of Heinz Europe from 2002 to 2006 and President and Chief Executive Officer of H.J. Heinz Company North America from 1999 to 2002. He was a Director of Colgate-Palmolive from 2010 to 2015 and AstraZeneca PLC, from 2002 to 2007. He provides a unique perspective to the Procter & Gamble Co Board on commercial, innovation, Marketing and strategic issues. He serves as Director of Teres Bio, Inc. Mr. Jimenez has B.A. in Marketing, Economics from Stanford University in 1982. Mr. Jimenez has M.B.A. from The University of California, Berkeley in 1984.

Positions